August 5th 2025, 4:00pm
An expert helps patients with metastatic breast cancer understand treatment sequencing, biomarker testing and emerging options to support decision-making.
July 15th 2025, 8:00pm
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
July 9th 2025, 4:00pm
Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, HER2-negative stage 4 breast cancer.
June 10th 2025, 4:00pm
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
April 25th 2025, 7:00pm
Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and provided subsequent updates.
November 27th 2024, 4:00pm
An expert discusses the next steps for patients with metastatic breast cancer after their disease no longer responds to hormone therapy.
October 21st 2024, 1:00pm
An expert discussed the importance of patients learning about their specific type of breast cancer to understand potential treatment options.
October 15th 2024, 3:00pm
An expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.
September 19th 2024, 7:00pm
Through communication and education, patients with metastatic breast cancer may be able to balance treatment with quality of life.
August 9th 2024, 1:00pm
An expert explained the importance of understanding different subtypes of metastatic breast cancer and available treatment options based on biomarker testing.
Understanding Stage 1 Polycythemia Vera: What Every Patient Should Know
How Vaccines Can Partner With Immunotherapy to Treat Lung Cancer
FDA Approves Imfinzi Plus Chemo in GC/GEJC
More Than a Cyst: The Fear Cancer Leaves Behind